Adam J Plaunt

Title: Adam J. Plaunt: Patent Activity in Pharmaceutical Innovation

Introduction

Adam J. Plaunt is an inventor associated with Bridgewater, New Jersey, and Insmed Incorporated. His patent work concerns pharmaceutical research, including compounds designed to inhibit dipeptidyl peptidase 1 (DPP1).

Latest Patents

Plaunt is associated with 1 patent: “Linear Dipeptidyl Peptidase 1 Inhibitors and Uses Thereof.” The patent describes compounds of Formula (I), including pharmaceutically acceptable salts and deuterated forms, as well as pharmaceutical compositions containing these compounds. It also describes methods for using them to treat diseases that may be treated with a DPP1 inhibitor.

Career Highlights

Plaunt’s identified patent activity is connected to Insmed Incorporated and focuses on potential therapeutic applications of DPP1 inhibitors. The patent describes a range of compounds and formulations for pharmaceutical use.

Collaborations

Gianpaolo Gobbo and Yingxin Shi are identified as Plaunt’s coworkers. Their shared association with Insmed reflects a professional context connected to pharmaceutical research and development.

Conclusion

Adam J. Plaunt’s patent record highlights his contribution to pharmaceutical innovation through work on DPP1 inhibitors and their potential therapeutic uses.